Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more effectively. The new approach could be a way to deliver treatment directly to tumors at higher doses, while reducing side effects in healthy tissue. The research is published in the journal Molecular Cancer Therapeutics.
This article was originally published on MedicalXpress.com

